Czechia vs Singapore: Cause of death, by non-communicable diseases, ages 60+
Czechia
73.6%
in 2021
Singapore
73.9%
in 2021
Czechia rank
79th
Singapore rank
78th
Cause of death, by non-communicable diseases, ages 60+ over time
- Czechia
- Singapore
How they compare
Singapore currently reports 73.9% against 73.6% in Czechia, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Czechia ahead.
Czechia ranks 79th and Singapore ranks 78th of 185 countries.
Czechia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Czechia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.6% | 81.9% | 11.7% | Czechia |
| 2010s | 91.6% | 74.2% | 17.4% | Czechia |
| 2020s | 78.2% | 74.7% | 3.6% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Czechia or Singapore?
- Singapore, at 73.9% against 73.6% in Czechia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Czechia and Singapore?
- 0.3%, with Singapore ahead.
- How many years of comparable data are there for Czechia and Singapore?
- 6 years are reported by both, from 2000 to 2021.
- How do Czechia and Singapore rank globally for cause of death, by non-communicable diseases, ages 60+?
- Czechia ranks 79th and Singapore ranks 78th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.